Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer

Saved in:

Bibliographic Details
Main Authors:	John Nemunaitis (Author), Laura Stanbery (Author), Adam Walter (Author), Rodney Rocconi (Author), Philip Stephens (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Society of Gynecologic Oncology Journal Club: Controversial conversations in gynecologic cancer - Navigating maintenance therapy for homologous recombinant proficient ovarian cancer
by: Whitney N. Goldsberry, et al.
Published: (2022)

Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance
by: Johnathan Oh, et al.
Published: (2020)

Corrigendum to "Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance" [Gynecol. Oncol. Rep. 34 (2020) 100648]
by: Jonathan Oh, et al.
Published: (2021)

RAD51 as a biomarker for homologous recombination deficiency in high‐grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test
by: Claire JH Kramer, et al.
Published: (2023)

Homology Molecular Modeling Perspectives and Applications
Published: (2021)

Homologous Recombination Pathway Alternation Predicts Prognosis of Colorectal Cancer With Chemotherapy
by: Yan Lin, et al.
Published: (2022)

Boosting CRISPR-Cas9 efficiency through enhanced homologous recombination
by: So Hyun Kim, et al.
Published: (2024)

Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma
by: Zheng Feng, et al.
Published: (2023)

Micelle encapsulation zinc‐doped copper oxide nanocomposites reverse Olaparib resistance in ovarian cancer by disrupting homologous recombination repair
by: Jingyan Yi, et al.
Published: (2023)

A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual level
by: Shuping Zhuang, et al.
Published: (2021)

High rates of homologous recombination in the mite endosymbiont and opportunistic human pathogen Orientia tsutsugamushi.
by: Piengchan Sonthayanon, et al.
Published: (2010)

Improved Double-Nicking Strategies for COL7A1-Editing by Homologous Recombination
by: Thomas Kocher, et al.
Published: (2019)

Homologous Recombination Repair Testing Patterns and Outcomes in mCRPC by Alteration Status and Race
by: Bilen MA, et al.
Published: (2024)

Homologous recombination deficiency score is an independent prognostic factor in esophageal squamous cell carcinoma
by: Yulu Wang, et al.
Published: (2024)

Homology Modeling and Molecular Docking of the Leishmania Protein Kinase, E9BJT5, A New Target for Leishmaniasis Therapeutics
by: Niloofar Lari, et al.
Published: (2020)

Virus-mediated Genetic Surgery: Homologous Recombination With a Little "Helper" From My Friends
by: Dieter C Gruenert, et al.
Published: (2012)

Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer
by: David Gonzalez, et al.
Published: (2021)

Adenomatous polyposis coli in cancer and therapeutic implications
by: Olivia Noe, et al.
Published: (2021)

Ovarian fibrosis: molecular mechanisms and potential therapeutic targets
by: Mengqing Gu, et al.
Published: (2024)

The Interaction of PI3K Inhibition with Homologous Recombination Repair in Triple Negative Breast Cancer Cells
by: Gamze Guney Eskiler
Published: (2019)

Aggressive prostate cancer with somatic loss of the homologous recombination repair gene FANCA: a case report
by: Hiroshi Hongo, et al.
Published: (2020)

Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets
by: Kaipeng Xie, et al.
Published: (2019)

Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types
by: Jan Budczies, et al.
Published: (2022)

Role of TRPM7 in Cancer: Potential as Molecular Biomarker and Therapeutic Target
by: Nelson S. Yee
Published: (2017)

A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations
by: Anne Vogel, et al.
Published: (2024)

2-Hydroxy-3-methylanthraquinone inhibits homologous recombination repair in osteosarcoma through the MYC-CHK1-RAD51 axis
by: Doudou Jing, et al.
Published: (2023)

Homologous recombination deficiency (HRD) is associated with better prognosis and possibly causes a non‐inflamed tumour microenvironment in nasopharyngeal carcinoma
by: Xinyi Zhou, et al.
Published: (2024)

Homology modeling of Leishmania donovani enolase and its molecular interaction with novel inhibitors
by: Jay Prakash Mahato, et al.
Published: (2017)

In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies
by: Aimee E. Mattei, et al.
Published: (2024)

Molecular Characterization of Cysteine Protease YopT from by Homology Modeling and Binding Site Identification
by: Md. Anayet Hasan, et al.
Published: (2014)

ACSL4 as a Potential Target and Biomarker for Anticancer: From Molecular Mechanisms to Clinical Therapeutics
by: Jun Hou, et al.
Published: (2022)

Reduction of Delayed Homologous Recombination by Induction of Radioadaptive Response in RaDR-GFP Mice (Yonezawa Effect): An Old Player With a New Role
by: Cuihua Liu, et al.
Published: (2019)

Somatic mutations in four novel genes contribute to homologous recombination deficiency in breast cancer: a real‐world clinical tumor sequencing study
by: Yongsheng Huang, et al.
Published: (2024)

Amyotrophic Lateral Sclerosis: Molecular Mechanisms, Biomarkers, and Therapeutic Strategies
by: Xiaoming Yang, et al.
Published: (2021)

Racial health disparities in ovarian cancer: not just black and white
by: Sanjeev K. Srivastava, et al.
Published: (2017)

HER2-positive metastatic cervical cancer responsive to first and second-line treatment: A case report
by: Dylan Fortman, et al.
Published: (2020)

Creation of a comprehensive proficiency testing program for molecular diagnosis in Brazil
by: Gustavo B. Barra, et al.
Published: (2017)

Protofibrillar Amyloid Beta Modulation of Recombinant hCaV2.2 (N-Type) Voltage-Gated Channels
by: Eleni Kaisis, et al.
Published: (2022)

Homology Modeling and Molecular Docking Studies of Selected Substituted Tetradecane on vlsE Borrelia spielmanii
by: Venu Paritala, et al.
Published: (2022)

Novel Approach to Proficiency Testing Highlights Key Practice Variations in Cancer Biomarker Delivery
by: Kassandra R. Bisson, et al.
Published: (2024)